The global goal to end new HIV infections by 2030 has sent all systems working. The dream is big and calls for business unusual. We have come to know that Science alone will not get us there. Science requires platforms and systems that will place evidence-based products in the hands of the users.
In a dynamic world where health disparities persist, partnerships that drive innovation and promote empowerment are invaluable.
The MOSAIC Project is a partnership of organizations that are committed to contributing to the goal of ending new HIV infections among adolescent girls and young women by ensuring they have a choice of selecting an HIV prevention method that meets their needs and preferences.
The project recently launched CATALYST, an implementation science study focused on answering how to provide women with the choice of HIV prevention method. The study is being implemented in five African countries, including Kenya, Lesotho, Uganda, South Africa and Zimbabwe.
In addition to education, the MOSAIC program endorses innovative biomedical tools to augment HIV prevention:
- Oral Pre-Exposure Prophylaxis (Oral PrEP): A medication that, when taken as directed, substantially reduces HIV transmission risk, particularly for high-risk individuals.
- Dapivirine Ring (PrEP Ring): A discreet, long-lasting vaginal ring releasing dapivirine to offer sustained HIV protection.
- Injectable Long-Acting Cabotegravir (CAB PrEP): Administered every two months, this injectable option suits those who struggle with daily pill regimens.
LVCT Health is part of the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) core consortium partners, which is comprised of Pangaea Zimbabwe AIDS Trust, based in Zimbabwe; Wits Reproductive Health and HIV Institute, based in South Africa; Jhpiego, a nonprofit organization affiliated with Johns Hopkins University; and New York City-based global HIV prevention advocacy group, AVAC.
Together with our core partners in the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC), we are proud to be at the forefront of advancing innovative approaches for HIV prevention and improving health outcomes.
Together, we envision a future free of HIV, where everyone can lead a healthy life.
Photo credit: Andrew Loxley, courtesy of the International Partnership for Microbicides